El vacío legal que habilita a médicos de cualquier especialidad a ofrecer tratamientos que ignoran
Dr. Keith A. Marcus injects Allergan Inc. Botox between a patient's eyes at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California, U.S., on Tuesday, April 22, 2014. Valeant Pharmaceuticals International Inc. offered to buy Allergan Inc., maker of the Botox wrinkle treatment, in a cash-and-stock deal valued at $45.7 billion in the latest step of the Canadian company's plan to become one of the world's largest drugmakers. Photographer: Patrick T. Fallon/Bloomberg *** Local Caption *** Keith A. Marcus

El vacío legal que habilita a médicos de cualquier especialidad a ofrecer tratamientos que ignoran

Fin del contenido

No hay más páginas por cargar